FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...